Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination

Vaccine

Volumn 26, Issue 44, 2008, Pages 5641-5648

  Miller, Annett ^a   Center, Rob J ^a   Stambas, John ^a   Deliyannis, Georgia ^a   Doherty, Peter C ^a   Howard, Jane L ^a   Turner, Stephen J ^a   Purcell, Damian F J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Influenza; Sindbis; Vaccine

Indexed keywords

DNA; HEMAGGLUTININ; HEMAGGLUTININ ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA; VIRUS VECTOR; VIRUS VECTOR PCI HA; VIRUS VECTOR PSIN HA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG FORMULATION; DRUG MEGADOSE; FEMALE; HUMORAL IMMUNITY; INFLUENZA; LONG TERM MEMORY; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPLICON; SINDBIS VIRUS; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; CRICETINAE; FEMALE; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PLASMIDS; REPLICON; SINDBIS VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 52949116362     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.102     Document Type: Article

References (38)

1. Ada G.L., and Jones P.D. The immune response to influenza infection. Curr Top Microbiol Immunol 128 (1986) 1-54
2. World Health Organization. Global pandemic influenza action plan to increase vaccine supply. Department of Immunization, Vaccines and Biologicals and the Department of Epidemic and Pandemic Alert and Response; 2006. pp. 1-14 [WHO/IVB/06.13; WHO/CDS/EPR/GIP/2006].
3. Ulmer J.B., Valley U., and Rappuoli R. Vaccine manufacturing: challenges and solutions. Nat Biotechnol 24 (2006) 1377-1383
4. Goodwin K., Viboud C., and Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24 (2006) 1159-1169
5. Thomas P.G., Keating R., Hulse-Post D.J., and Doherty P.C. Cell-mediated protection in influenza infection. Emerg Infect Dis 12 (2006) 48-54
6. Renegar K.B., Small Jr. P.A., Boykins L.G., and Wright P.F. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 173 (2004) 1978-1986
7. Andrew M.E., Coupar B.E., Boyle D.B., and Ada G.L. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand J Immunol 25 (1987) 21-28
8. Mozdzanowska K., Maiese K., and Gerhard W. Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance. J Immunol 164 (2000) 2635-2643
9. Lin Y.L., and Askonas B.A. Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med 154 (1981) 225-234
10. Yap K.L., Ada G.L., and McKenzie I.F. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273 (1978) 238-239
11. Driver D.A., Latham E.M., Polo J.M., Belli B.A., Banks T.A., Chada S., et al. Layered amplification of gene expression with a DNA gene delivery system. Ann N Y Acad Sci 772 (1995) 261-264
12. Dubensky Jr. T.W., Driver D.A., Polo J.M., Belli B.A., Latham E.M., Ibanez C.E., et al. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol 70 (1996) 508-519
13. Herweijer H., Latendresse J.S., Williams P., Zhang G., Danko I., Schlesinger S., et al. A plasmid-based self-amplifying Sindbis virus vector. Hum Gene Ther 6 (1995) 1161-1167
14. Hariharan M.J., Driver D.A., Townsend K., Brumm D., Polo J.M., Belli B.A., et al. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol 72 (1998) 950-958
15. Kamrud K.I., Hooper J.W., Elgh F., and Schmaljohn C.S. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters. Virology 263 (1999) 209-219
16. Frolov I., and Schlesinger S. Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells. J Virol 68 (1994) 1721-1727
17. Leitner W.W., Hwang L.N., de Veer M.J., Zhou A., Silverman R.H., Williams B.R.G., et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 9 (2003) 33-39
18. Berglund P., Fleeton M.N., Smerdou C., and Liljestrom P. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice. Vaccine 17 (1999) 497-507
19. Fleeton M.N., Chen M., Berglund P., Rhodes G., Parker S.E., Murphy M., et al. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus. J Infect Dis 183 (2001) 1395-1398
20. Davis N.L., Brown K.W., and Johnston R.E. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J Virol 70 (1996) 3781-3787
21. Pushko P., Parker M., Ludwig G.V., Davis N.L., Johnston R.E., and Smith J.F. Replicon-helper systems from attenuated Venezuelan Equine Encephalitis Virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239 (1997) 389-401
22. Hahn C.S., Hahn Y.S., Braciale T.J., and Rice C.M. Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc Natl Acad Sci USA 89 (1992) 2679-2683
23. Tsuji M., Bergmann C.C., Takita-Sonoda Y., Murata K.-I., Rodrigues E.G., Nussenzweig R.S., et al. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. J Virol 72 (1998) 6907-6910
24. Staudt L.M., and Gerhard W. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J Exp Med 157 (1983) 687-704
25. Reading P.C., Miller J.L., and Anders E.M. Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol 74 (2000) 5190-5197
26. Jackson D.C., Tang X.L., Brown L.E., Murray J.M., White D.O., and Tregear G.W. Antigenic determinants of influenza virus hemagglutinin. XII. The epitopes of a synthetic peptide representing the C-terminus of HA1. Virology 155 (1986) 625-632
27. Harling-McNabb L., Deliyannis G., Jackson D.C., Gerondakis S., Grigoriadis G., and Brown L.E. Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response. Int Immunol 11 (1999) 1431-1439
28. Tannock G.A., Paul J.A., and Barry R.D. Relative immunogenicity of the cold-adapted influenza virus a/ann arbor/6/60 (a/aa/6/60-ca), recombinants of a/aa/6/60-ca, and parental strains with similar surface antigens. Infect Immun 43 (1984) 457-462
29. Ben-Ahmeida E.T., Potter C.W., Gregoriadis G., Adithan C., and Jennings R. IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines. J Med Microbiol 40 (1994) 261-269
30. Kuwano K., Braciale T.J., and Ennis F.A. Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. Viral Immunol 2 (1989) 163-173
31. Kuwano K., Reyes V.E., Humphreys R.E., and Ennis F.A. Recognition of disparate HA and NS1 peptides by an H-2kd-restricted, influenza specific CTL clone. Mol Immunol 28 (1991) 1-7
32. Tamura M., Kuwano K., Kurane I., and Ennis F.A. Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones. J Virol 72 (1998) 9404-9406
33. Lau Y.F., Deliyannis G., Zeng W., Mansell A., Jackson D.C., and Brown L.E. Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines. Int Immunol 18 (2006) 1801-1813
34. Brand D., Lemiale F., Turbica I., Buzelay L., Brunet S., and Barin F. Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles. AIDS Res Hum Retroviruses 14 (1998) 1369-1377
35. Deliyannis G., Boyle J.S., Brady J.L., Brown L.E., and Lew A.M. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc Natl Acad Sci USA 97 (2000) 6676-6680
36. Boyle J.S., Brady J.L., and Lew A.M. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392 (1998) 408-411
37. Li W. Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen. Immunology 115 (2005) 215-222
38. Kuwano K., Scott M., Young J.F., and Ennis F.A. Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes. J Exp Med 169 (1989) 1361-1371